Akılcı İlaç Kullanımı
Özet
İlaçlar, sağlık hizmetlerinin ayrılmaz bir parçasıdır. Ancak, çoğu ülkede genel sağlık harcamalarının önemli bir bölümünü oluşturmanın yanısıra oldukça maliyetli ürünlerdir. İlaçların akılcı olmayan kullanımı, dünya çapında birçok sağlık sisteminin karşılaştığı büyük bir sorundur. Bu tür uygulamalar, hastaları riske atabilecek ve diğer acil sağlık ihtiyaçlarını karşılamak için kullanılabilecek kıt kaynakların israfına yol açabilecek kötü sağlık hizmeti sunumuna neden olabilmektedir. "İlaçların akılcı kullanımı" kavramı, zaman zaman kafa karıştırıcı olabilir ve bu zorluğun üstesinden gelmek için etkili bir şekilde iş birliği yapması gereken hastalar, sağlık hizmeti sağlayıcıları, politika üreticileri veya halk tarafından kolayca anlaşılamayabilir. Bu derlemede, akılcı ilaç kullanımı, iyi reçete yazma ve dağıtım gibi temel kavramlarının yanında ilaçların akılcı olmayan kullanımına katkıda bulunan bazı faktörleri ve bu tür uygulamaların potansiyel etkileri yer almaktadır. Aynı zamanda sağlık profesyonelleri, hastalar ve halk için temel ilaç kullanım kavramlarının açık, özlü ve kolay anlaşılır bir açıklamasını sunma amacıyla yazılmıştır.
Medicines are an essential component of healthcare. However, they are costly products, accounting for a significant portion of overall healthcare expenditure in most countries. The irrational use of medicines is a major problem facing many healthcare systems worldwide. Such practices can lead to poor healthcare delivery, which can put patients at risk and waste scarce resources that could be used to meet other urgent healthcare needs. The concept of ‘rational use of medicines’ can sometimes be confusing and not easily understood by patients, healthcare providers, policy makers or the public, who must collaborate effectively to overcome this challenge. The fundamental principles of rational medicine use, effective prescribing and dispensing, as well as some of the factors that contribute to irrational medicine use and the potential consequences of such practices, are discussed in this review. It is also intended to provide a clear, concise and easily understandable explanation of the basic concepts of medicine use for healthcare professionals, patients and the public.
Referanslar
Management sciences for health (MSH), Managing Drug Supply. 2nd edition. (revised and expanded), kumarian press. west hart Ford, Conn,USA; 1997.
World Health Organization. How to Investigate Drug Use in Health Facilities: Selected Drug Use Indicators. Geneva: World Health Organization; 1993.
Drug Administration and Control Authority. Manual on Drug Supply Management. Addis Ababa, Ethiopia: Prepared by department of DACA;1996.
World Health Organization. Promoting Rational Use of Medicines:Core Components. Geneva: World Health Organization; 2002.
World Health Organization, The world medicines situations: chapter 8, rational use of medicines, 2010. Available from: http://apps.who.int/medicinedocs/en/d/JS/6160e/10.html.
Drug Administration and Control Authority. Training Modules on
Operation and Management of Special Pharmacies. Ethiopia:
Birhane selam printing enterprise; 2003. Available from: http://daca.gov.et./downloads.html.
World Health Organization. The Role of the Pharmacist in the Health Care System: Preparing the Future Pharmacist: Curricular Development: Report of a Third WHO Consultative Group on the
Role of the Pharmacist, Vancouver, Canada, 27–29 August 1997.
Geneva: World Health Organization; 1997.
World Health Organization. World Medicines Situation Report 2011; World Health Organization: Geneva, Switzerland, 2011.
World Health Organization. The World Medicines Situation;World Health Organization: Geneva, Switzerland, 2004.
Ofori-Asenso R, Brhlikova P, Pollock AM. Prescribing indicators at primary health care centers within the WHO African region: a systematic analysis (1995–2015). BMC public health. 2016;16:1-14. doi:
Almarsdóttir AB, Traulsen JM. Rational use of medicines–an important issue in pharmaceutical policy. Pharmacy World and Science. 2005;27:76-80. doi:
Seiter, A. A Practical Approach to Pharmaceutical Policy; The World Bank: Washington, DC, USA, 2010.
World Health Organization. Health Action International: Measuring Medicine Prices, Availability, Affordability and Price Components, 2nd ed.;World Health Organization: Geneva, Switzerland, 2008.
Shivhare S, Kunjwani H, Manikrao A, Bondre A. Drugs hazards and rational use of drugs: a review. Journal of Chemical and Pharmaceutical Research. 2010;2(1):106-12.
Gopalakrishnan S, Udayshankar P, Rama R. Standard treatment guidelines in primary healthcare practice. Journal of family medicine and primary care. 2014;3(4):424-9. doi: 10.4103/2249-4863.148134.
Management Sciences for Health. MDS-3-Managing Access to Medicines and Health Technologies; Management Sciences for Health (MSH): Arlington, VA, USA, 2012.
World Health Organization. Rational use of drugs: A review of major issues. In Proceedings of the Conference of Experts, Nairobi, Kenya, 22–29 November 1985.
May F. Whither ‘rational’ use of drugs? Journal of Pharmacy Practice and Research. 2008; 38: 89–91. doi:10.1002/j.2055-2335.2008.tb00808.x
Brahma D, Marak M, Wahlang J. Rational use of drugs and irrational drug combinations. The Internet Journal of Pharmacology. 2012;10(1):1-5. doi:10.5580/2b59
Laing R, Waning B, Gray A, Ford N, Hoen Et. 25 years of the WHO essential medicines lists: progress and challenges. The Lancet. 2003;361(9370):1723-1729. doi: 10.1016/S0140-6736(03)13375-2.
Ofori-Asenso R. A closer look at the World Health Organization's prescribing indicators. Journal of Pharmacology and Pharmacotherapeutics. 2016;7(1):51-4. doi: 10.4103/0976-500X.179352
Maxwell SR. Rational prescribing: the principles of drug selection. Clinical medicine. 2016;16(5):459-64. doi: 10.7861/clinmedicine.16-5-459
Pollock M, Bazaldua OV, Dobbie AE. Appropriate prescribing of medications: an eight-step approach. American family physician. 2007;75(2):231-6.
Maxwell S. Rational prescribing: the principles of drug selection. Clinical medicine. 2009;9(5):481-485. doi: 10.7861/clinmedicine.9-5-481
Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clinical therapeutics. 2001;23(8):1296-310. doi: 10.1016/s0149-2918(01)80109-0.
Elwyn G, Edwards A, Britten N. “Doing prescribing”: how doctors can be more effective. British medical journal 2003;327(7419):864-7. doi: 10.1136/bmj.327.7419.864.
Britten N, Stevenson FA, Barry CA, Barber N, Bradley CP. Misunderstandings in prescribing decisions in general practice: qualitative study. British medical journal. 2000;320(7233):484-8. doi: 10.1136/bmj.320.7233.484.
Ha JF, Longnecker N. Doctor-patient communication: a review. Ochsner journal. 2010;10(1):38-43.
Dong R. Paternalism In Medical Decision Making; Duke University: Durham, NC, USA, 2011.
Entwistle VA, Carter SM, Cribb A, McCaffery K. Supporting patient autonomy: the importance of clinician-patient relationships. Journal of general internal medicine. 2010;25:741-5. doi: 10.1007/s11606-010-1292-2
King A, Hoppe RB. “Best practice” for patient-centered communication: a narrative review. Journal of graduate medical education. 2013;5(3):385-93. doi: 10.4300/JGME-D-13-00072.1.
Halczli A, Woolley AB. Medication underdosing and underprescribing: Issues that may contribute to polypharmacy, poor outcomes. Formulary. 2013;48(6).
Van Den Heuvel PML, Los M, Van Marum RJ, Jansen PA. Polypharmacy and underprescribing in older adults: rational underprescribing by general practitioners. Journal of the American Geriatrics Society. 2011;59(9):1750-2. doi: 10.1111/j.1532-5415.2011.03548.x.
Wauters M, Elseviers M, Vaes B, Degryse J, Dalleur O, Vander Stichele R, et al. Too many, too few, or too unsafe? Impact of inappropriate prescribing on mortality, and hospitalization in a cohort of community‐dwelling oldest old. British journal of clinical pharmacology. 2016;82(5):1382-92. doi: 10.1111/bcp.13055.
Llor C, Bjerrum L. Antimicrobial resistance: risk associated with antibiotic overuse and initiatives to reduce the problem. Therapeutic advances in drug safety. 2014;5(6):229-41. doi: 10.1177/2042098614554919.
Fiedorowicz JG, Swartz KL. The role of monoamine oxidase inhibitors in current psychiatric practice. Journal of Psychiatric Practice®. 2004;10(4):239-48. doi: 10.1097/00131746-200407000-00005
Godman B, Shrank W, Andersen M, Berg C, Bishop I, Burkhardt T, et al. Comparing policies to enhance prescribing efficiency in Europe through increasing generic utilization: changes seen and global implications. Expert review of pharmacoeconomics & outcomes research. 2010;10(6):707-22. doi: 10.1586/erp.10.72.
Godman B, Wettermark B, Van Woerkom M, Fraeyman J, Alvarez-Madrazo S, Berg C, et al. Multiple policies to enhance prescribing efficiency for established medicines in Europe with a particular focus on demand-side measures: findings and future implications. Frontiers in pharmacology. 2014;5:106. doi: 10.3389/fphar.2014.00106
Gurbani N. Problems and impact of irrational medicines: Use and tools & interventions to improve medicines use. Pharma Times. 2011;43(7):23-4.
Md Rezal RS, Hassali MA, Alrasheedy AA, Saleem F, Md Yusof FA, Godman B. Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature. Expert review of anti-infective therapy. 2015;13(5):665-80. doi: 10.1586/14787210.2015.1025057
Macfarlane J, Holmes W, Macfarlane R, Britten N. Influence of patients' expectations on antibiotic management of acute lower respiratory tract illness in general practice: questionnaire study. British medical journal. 1997;315(7117):1211-4. doi: 10.1136/bmj.315.7117.1211.
Naicker S, Plange-Rhule J, Tutt RC, Eastwood JB. Shortage of healthcare workers in developing countries—Africa. Ethnicity & disease. 2009;19:60-4.
Spurling GK, Mansfield PR, Montgomery BD, Lexchin J, Doust J, Othman N, et al. Information from pharmaceutical companies and the quality, quantity, and cost of physicians' prescribing: a systematic review. PLoS medicine. 2010;7(10):e1000352. doi: 10.1371/journal.pmed.1000352.
Ching A, Ishihara M. The effects of detailing on prescribing decisions under quality uncertainty. Quantitative Marketing and Economics. 2010;8:123-65.
Davis, C.; Abraham, J. Is there a cure for corporate crime in the drug industry? British Medical Journal. 2013, 346, f755. doi: 10.1136/bmj.f755.
Hamilton HJ, Gallagher PF, O'Mahony D. Inappropriate prescribing and adverse drug events in older people. BioMed Central geriatrics. 2009;9:1-4. doi: 10.1186/1471-2318-9-5
Lederberg J. Infectious history. Science. 2000;288(5464):287-93. doi: 10.1126/science.288.5464.287.
Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharmacy and therapeutics. 2015;40(4):277.
World Health Organization. Antimicrobial Resistance: Global Report on Surveillance;World Health Organization:Geneva, Switzerland, 2014.
Aina BA, Tayo F, Taylor O. Cost implication of irrational prescribing of chloroquine in Lagos State general hospitals. The Journal of Infection in Developing Countries. 2008;2(01):068-72.
World Health Organization. Teacher’s Guide to Good Prescribing; World Health Organization: Geneva,Switzerland, 2001.
Hogerzeil HV. Promoting rational prescribing: an international perspective. British journal of clinical pharmacology. 1995;39(1):1-6. doi: 10.1111/j.1365-2125.1995.tb04402.x
Kamarudin G, Penm J, Chaar B, Moles R. Educational interventions to improve prescribing competency: a systematic review. British Medical Journal open. 2013;3(8):e003291. doi: 10.1136/bmjopen-2013-003291.
Sabuncu E, David J, Bernède-Bauduin C, Pépin S, Leroy M, Boëlle P-Y, et al. Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002–2007. PLoS medicine. 2009;6(6):e1000084. doi: 10.1371/journal.pmed.1000084
Fürst J, Čižman M, Mrak J, Kos D, Campbell S, Coenen S, et al. The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications. Expert review of anti-infective therapy. 2015;13(2):279-89. doi: 10.1586/14787210.2015.990381
